These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8744680)

  • 1. Reactivity of monoclonal antibodies OK-CLL (anti-CD5) with peripheral blood cells of patients with B cell lymphoproliferative disorders.
    Milosević D; Marinković M; Jelić S; Colović M; Spuzić I
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):23-9. PubMed ID: 8744680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
    Cabezudo E; Carrara P; Morilla R; Matutes E
    Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
    Rutella S; Rumi C; Puggioni P; Barberi T; Di Mario A; Larocca LM; Leone G
    Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1997 Sep; 10(9):859-63. PubMed ID: 9310947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative flow cytometric evaluation of bcl-2 oncoprotein in CD5+ and CD5- B-cell lymphoid chronic leukemias.
    Molica S; Mannella A; Crispino G; Dattilo A; Levato D
    Haematologica; 1997; 82(5):555-9. PubMed ID: 9407720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.
    Novak AJ; Grote DM; Ziesmer SC; Kline MP; Manske MK; Slager S; Witzig TE; Shanafelt T; Call TG; Kay NE; Jelinek DF; Cerhan JR; Gross JA; Harder B; Dillon SR; Ansell SM
    J Clin Oncol; 2006 Feb; 24(6):983-7. PubMed ID: 16432079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
    Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
    Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiology of chronic lymphocytic leukemia.
    Freedman AS
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):405-29. PubMed ID: 2182599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.
    Rawstron AC; Bennett F; Hillmen P
    Br J Haematol; 2007 Dec; 139(5):724-9. PubMed ID: 18021087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The absence of correlation between immunoregulatory T cells and induced lymphoproliferative response in treated B-chronic lymphocytic leukemia patients.
    Milosević D; Marinković M; Colović M; Jelić S
    Panminerva Med; 1999 Jun; 41(2):93-7. PubMed ID: 10479904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma.
    Jevremovic D; Dronca RS; Morice WG; McPhail ED; Kurtin PJ; Zent CS; Hanson CA
    Leuk Res; 2010 Sep; 34(9):1235-8. PubMed ID: 20362334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
    Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
    Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance.
    Zucchetto A; Sonego P; Degan M; Bomben R; Dal Bo M; Russo S; Attadia V; Rupolo M; Buccisano F; Steffan A; Del Poeta G; Pucillo C; Colombatti A; Campanini R; Gattei V
    J Immunol Methods; 2005 Oct; 305(1):20-32. PubMed ID: 16198366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders.
    Lúcio PJ; Faria MT; Pinto AM; da Silva MR; Correia Júnior ME; da Costa RJ; Parreira AB
    Haematologica; 1998 Feb; 83(2):104-11. PubMed ID: 9549920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.